According to IMARC Group latest report titled “North America Travel Vaccines Market: Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a comprehensive analysis of the industry, which comprises insights on . The report also includes competitor and regional analysis, and contemporary advancements in the market. The North America travel vaccines market size reached US$ 1.7 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 2.5 Billion by 2027, exhibiting a growth rate (CAGR) of 6.89% during 2022-2027.
Vaccines are biological preparations that aid in protecting the human body against severe diseases. They comprised an agent produced from the surface toxins, proteins and weakened or killed disease-causing microorganisms. They are generally given to travelers before they visit certain regions in order to prevent the occurrence of deadly diseases. As a result, they are recommended vaccines that help in preventing a potential infection threat in the country. Some of the most common travel-related diseases include meningitis, tick-borne encephalitis, diphtheria, pertussis, influenza, rabies, polio, and tetanus.
Request to Get the Free Sample Report: https://www.imarcgroup.com/north-america-travel-vaccines-market/requestsample
Market Trends:
The rising prevalence of chronic diseases among individuals majorly drives the market in North America. In addition to this, numerous initiatives undertaken by the regulatory authorities to mandate prior vaccination for travelers before traveling to disease-prone regions with a high risk of exposure are significantly supporting its demand. Along with this, significant growth in the tourism sector and the increasing number of international tourist arrivals across the region are providing an impetus to the market growth. Moreover, continual technological advancements, such as the introduction of needle-free techniques and combination vaccines are creating a positive market outlook in North America. Other factors driving the market further include rising awareness among the masses and extensive research and development (R&D) activities conducted by key players.
Explore Full Report with Table of Contents:
North America Travel Vaccines Market Segmentation:
Our report has categorized the market based on region, composition and disease.
Key Regions Analysed:
- United States
- Canada
- Mexico
Market by Composition:
- Mono Vaccines
- Combination Vaccines
Market by Disease:
- Hepatitis A
- DPT
- Yellow Fever
- Typhoid
- Hepatitis B
- Measles and Mumps
- Rabies
- Meningococcal
- Varicella
- Japanese Encephalitis
- Others
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022-2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
We are updating our reports, If you want latest primary and secondary data (2023-2028) with Cost Module, Business Strategy, Competitive landscape, etc. Click request free sample report, the report will be delivered to you in PDF format via email within 24 to 48 hours after the payment confirmation.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US:
IMARC Group
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
